Overcome the most common challenges in cell & gene therapy development using Droplet Digital PCR

Time: To be announced
To be announced
 Rosario Tizzone


With advances in techniques like CRISPR gene editing and the use of viral vectors, the number of gene therapy trials has rapidly grown in recent years, promising to deliver solutions to diseases that were previously considered untreatable.

There are however several challenges facing the developers of these therapies, including low vector concentration, empty capsids, contaminating host cell DNA, contamination by mycoplasmas and the common thread amongst these is the need for rigorous quality control. Here we will look in more detail at how ddPCR can be used to overcome some of these challenges and help guarantee safe and effective gene therapies.
To view the video assoicated with this lecture click here

Hosted By

The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Event Logo

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
Eventflo Home
copyright ELRIG, eventflo.co.uk, Labhoo Ltd 2003-2021